SBBP - Strongbridge Biopharma plc (SBBP) CEO John Johnson on Q3 2020 Results - Earnings Call Transcript

Strongbridge Biopharma plc (SBBP) Q3 2020 Earnings Conference Call Oct 29, 2020, 04:30 PM ET Company Participants Lindsay Rocco - Elixir Health, Public Relations John Johnson - CEO Fred Cohen - Chief Medical Officer Rob Lutz - CFO Scott Wilhoit - Chief Commercial Officer Rich Kollender - COO Conference Call Participants Annabel Samimy - Stifel Chris Howerton - Jefferies Justin Kim - Oppenheimer Jonathan Wolleben - JMP Securities Presentation Operator Good afternoon, ladies and gentlemen and welcome to Strongbridge Biopharma’s Plc Corporate Update and Q3 2020 Earnings Conference Call. At this time, all participants are in a listen only mode. LATER we'll conduct a question-and-answer session. Instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. I’d now like to hand the conference over to your host, Ms. Lindsay Rocco. Ma'am, please go ahead. Lindsay Rocco Thank you and good afternoon, everyone. We are

For further details see:

Strongbridge Biopharma plc (SBBP) CEO John Johnson on Q3 2020 Results - Earnings Call Transcript